Search

The U.S. drug industry's main lobbying group said it filed a lawsuit challenging the constitutionality of a California law meant to make drug prices more transparent. In its statement, PhRMA said that the California law "singles out drug manufacturers as the sole determinant of drug costs.". [Extracted from the article]

Proposition 61 is state's most expensive ballot fight of 2016 Drugmakers are becoming increasingly vocal in fighting a California ballot proposition on drug prices, concerned that the more $100 million in funding raised by lobbies opposing the initiative won't be enough to stop it. The pharmaceutical industry has been under fire for how it prices its medications, with Mylan NV's $600 EpiPen pack and Turing Pharmaceuticals AG's 50-fold increase of an anti-parasitic's price in the national spotlight. [Extracted from the article]

Theranos Inc. filed a plan to U.S. regulators to fix serious deficiencies at the company's blood-testing lab in Newark, California, as founder Elizabeth Holmes works to regain credibility for her struggling startup. Attribution Caroline Chen: by reporter John Lauerman: editor Stephen West: editor Drew Armstrong: editor responsible Zachary Tracer: by reporter. [Extracted from the article]

Blood-testing startup still works with Walgreens in Arizona Attribution Caroline Chen: by reporter John Lauerman: editor Drew Armstrong: editor responsible Cecile Daurat: editor Zachary Tracer: by reporter. [Extracted from the article]

California health officials are working the phones and ordering up hundreds of blood tests as they seek to curb the measles outbreak that has infected almost a hundred people in the state. Measles is airborne, so even in a doctor's waiting room, a patient could infect the people around him, Zahn said. [Extracted from the article]